News
Vertex, Entrada Establish EEV Therapeutics Alliance for Myotonic Dystrophy
Vertex Pharmaceuticals and Entrada Therapeutics, Inc. entered a global collaboration focused on discovering and developing intracellular Endosomal Escape Vehicle (EEV™) therapeutics for myotonic dystrophy type 1 (DM1). The collaboration includes Entrada’s program for DM1, ENTR-701, which is in late-stage...
BioPharma
Emmes Launches Cell and Gene Therapy Center
Emmes, a global, full-service Clinical Research Organization (CRO) dedicated to supporting the advancement of public health and biopharmaceutical innovation announced the creation of a dedicated center to enhance Emmes' legacy and depth in cell and gene therapy research.
The new...
News
Strong Expansion Predicted For Medical Device Packaging
Between 2022 and 2027, the market for medical device packaging is anticipated to expand by $15.66 billion at a CAGR of 10.16%.
In the research published by Technavio in November, it was predicted that Europe would contribute 29% of the...
News
Possible Future Biotech Systems May Rely Heavily On Urine
A mechanism that employs urea to begin the manufacturing of proteins in the massive amounts required by the biotech industry has been developed by researchers at the Universities of Birmingham and Aston.
Typically, in this procedure, little DNA fragments are...
News
Concerns Are Raised By Kidney Research UK Over NICE Process
The National Institute for Health and Care Excellence's (NICE) draught guidance on medicines for COVID-19 patients has received a response from Kidney Research UK.
It comes after the regulatory authority decided to drastically cut the number of therapies offered. The...
News
First Time Getting A Vaccine? 3 Benefits And 3 Risks
Although vaccinations have been around for decades, questions about their safety and effectiveness persist. You, like most people, probably got vaccinated because you believe it to be the safest and most effective way to stay healthy. However, if you're...
News
WHO Report Says That AMR Surveillance Has To Be Strengthened
Common bacterial illnesses are getting more and more resistant to treatments, according to the World Health Organization's (WHO) Global Antimicrobial Resistance and Use Surveillance System (GLASS) report 2022, which includes AMR tendencies for the first time since 2017.
Information from...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.